Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
2.120
-0.060 (-2.75%)
At close: Nov 19, 2026, 4:00 PM EST
2.125
+0.005 (0.24%)
After-hours: Nov 19, 2026, 7:39 PM EST
Minerva Neurosciences Market Cap
Minerva Neurosciences has a market cap or net worth of $105.65 million as of November 19, 2026. It is the 24,508th most valuable company in the world and the 3,981st biggest in the United States. Its market cap has increased by 251.00% in one year.
Market Cap
105.65M
Enterprise Value
88.71M
1-Year Change
251.00%
Global Rank
Country Rank
#3,981 United States
Category
ChartMarket Cap Chart
Since July 1, 2014, Minerva Neurosciences's market cap has decreased from $110.60M to $105.65M, a decrease of -4.47%. That is a compound annual growth rate of -0.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 105.65M | 275.98% |
| Dec 31, 2025 | 28.10M | 81.29% |
| Dec 31, 2024 | 15.50M | -63.95% |
| Dec 29, 2023 | 43.00M | 405.88% |
| Dec 30, 2022 | 8.50M | -75.15% |
| Dec 31, 2021 | 34.20M | -65.77% |
| Dec 31, 2020 | 99.90M | -64.00% |
| Dec 31, 2019 | 277.50M | 5.92% |
| Dec 31, 2018 | 262.00M | 11.92% |
| Dec 29, 2017 | 234.10M | -42.76% |
| Dec 30, 2016 | 409.00M | 172.49% |
| Dec 31, 2015 | 150.10M | 35.23% |
| Dec 31, 2014 | 111.00M | 0.36% |
| Jul 1, 2014 | 110.60M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Armata Pharmaceuticals | 110.83M |
| NRx Pharmaceuticals | 110.32M |
| Upstream Bio | 109.62M |
| Retension Pharmaceuticals | 108.39M |
| Foghorn Therapeutics | 106.73M |
| LENZ Therapeutics | 104.94M |
| Unicycive Therapeutics | 103.02M |
| Genelux | 102.17M |